Encompass Health Corporation
General ticker "EHC" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $11.2B (TTM average)
Encompass Health Corporation does not follow the US Stock Market performance with the rate: -2.3%.
Estimated limits based on current volatility of 1.2%: low 119.83$, high 122.31$
Factors to consider:
- Company pays dividends (irregularly): last record date 2026-07-01, amount 0.19$ (Y0.16%)
- Total employees count: 42000 (+5.0%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Reimbursement decline, Regulatory and compliance, Market competition, Integration failure, Public health crises
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [95.20$, 137.10$]
- 2026-12-31 to 2027-12-31 estimated range: [100.38$, 143.71$]
Financial Metrics affecting the EHC estimates:
- Negative: with PPE of 19.6 at the end of fiscal year the price was very high
- Positive: 7.80 < Operating profit margin, % of 17.74
- Positive: 6.77 < Operating cash flow per share per price, % of 10.91
- Positive: 18.97 < Shareholder equity ratio, % of 34.39 <= 42.26
- Positive: -14.39 < Investing cash flow per share per price, % of -7.09
- Negative: 0.75 < Interest expense per share per price, % of 1.14
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.40 > 6.06
- Positive: 0 < Industry operating cash flow per share per price (median), % of 4.90
Short-term EHC quotes
Long-term EHC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $4,801.20MM | $5,258.30MM | $5,935.20MM |
| Operating Expenses | $3,076.40MM | $4,508.70MM | $4,882.10MM |
| Operating Income | $1,724.80MM | $749.60MM | $1,053.10MM |
| Non-Operating Income | $-1,117.60MM | $0.00MM | $-100.10MM |
| Interest Expense | $143.50MM | $137.40MM | $123.20MM |
| Income(Loss) | $607.20MM | $749.60MM | $953.00MM |
| Taxes | $132.20MM | $150.20MM | $192.90MM |
| Other Income(Loss) | $-12.00MM | $-2.80MM | $-1.00MM |
| Net Income(Loss)* | $352.00MM | $455.70MM | $566.20MM |
| Stockholders Equity | $1,647.50MM | $2,067.00MM | $2,438.20MM |
| Assets | $6,102.40MM | $6,534.70MM | $7,089.70MM |
| Operating Cash Flow | $850.80MM | $1,002.80MM | $1,175.60MM |
| Capital expenditure | $583.10MM | $642.50MM | $736.40MM |
| Investing Cash Flow | $-602.80MM | $-653.30MM | $-764.60MM |
| Financing Cash Flow | $-197.20MM | $-330.60MM | $-431.20MM |
| Earnings Per Share** | $3.54 | $4.56 | $5.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.